Endeavor

TIL Therapy Research Expanded to Bladder Cancer

Almost half of patients enrolled in a Moffitt trial responded to the cellular immunotherapy

Blood Test May Help Detect Bladder Cancer Recurrence Earlier

Moffitt researchers study circulating tumor DNA to improve surveillance after bladder-preserving therapy

FDA Approves Inlexzo, a New Bladder Cancer Treatment

New device delivers therapy with fewer hospital visits

Deion Sanders Had Bladder Removed After Cancer Diagnosis

Colorado head coach stresses the importance of early detection after lifesaving surgery

Pretzel-Shaped Device Could Make a Big Difference in Bladder Cancer Treatment

Doctors test a new drug-delivery system designed to fight bladder cancer from the inside out

Honest Conversations Around Cancer

A three-time cancer survivor, Heidi Bragg tackles the toughest topics

Dr. Philippe Spiess Honored as Moffitt Physician of the Year

The genitourinary oncologist strives to form a personal connection with each patient

Blood Test Boosts Accuracy in Staging and Treating Upper Tract Urothelial Carcinoma

Circulating tumor DNA offers a noninvasive way to predict cancer severity

Sarasota Patient Finds Care Closer to Home at Moffitt at SouthShore

Ruskin location will serve 9,000 patients throughout the Tampa Bay area in the first five years